secwatch.observer — SEC 8-K summary
======================================

Issuer:     Glucotrack, Inc. (GCTK)
CIK:        0001506983
Form:       8-K
Filed at:   2026-01-29T23:59:59+00:00
Accession:  0001493152-26-004158
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Glucotrack receives USPTO approval for three CBGM patents
---------------------------------------------------------

- Three US patents issued by USPTO: US 12,453,494 (Oct 28, 2025), US 12,458,257 and US 12,458,258 (Nov 4, 2025).
- Patents protect proprietary sensor chemistry, intravascular lead design, and low-power electronics for the CBGM platform.
- The patents strengthen Glucotrack's competitive position and IP protection as it advances its implantable CBGM toward commercialization.
- Glucotrack's CBGM is a long-term implantable device with up to 3-year sensor longevity, no wearable component, and direct blood glucose measurement.
- The system measures glucose from blood, aiming to provide real-time readings with less lag than interstitial fluid sensors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506983/000149315226004158/0001493152-26-004158-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506983/000149315226004158/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-004158

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer